NM_003119.4:c.2063G>A

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 4P and 20B. PM1PM5BP4_StrongBP6_Very_StrongBA1

The NM_003119.4(SPG7):​c.2063G>A​(p.Arg688Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.174 in 1,612,442 control chromosomes in the GnomAD database, including 26,151 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R688W) has been classified as Likely pathogenic.

Frequency

Genomes: 𝑓 0.13 ( 1644 hom., cov: 33)
Exomes 𝑓: 0.18 ( 24507 hom. )

Consequence

SPG7
NM_003119.4 missense

Scores

2
3
10

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: 9.61

Publications

66 publications found
Variant links:
Genes affected
SPG7 (HGNC:11237): (SPG7 matrix AAA peptidase subunit, paraplegin) This gene encodes a mitochondrial metalloprotease protein that is a member of the AAA family. Members of this protein family share an ATPase domain and have roles in diverse cellular processes including membrane trafficking, intracellular motility, organelle biogenesis, protein folding, and proteolysis. Mutations in this gene cause autosomal recessive spastic paraplegia 7. Two transcript variants encoding distinct isoforms have been identified. [provided by RefSeq, Mar 2014]
SPG7 Gene-Disease associations (from GenCC):
  • hereditary spastic paraplegia 7
    Inheritance: AR, AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Laboratory for Molecular Medicine, G2P, Orphanet, Labcorp Genetics (formerly Invitae)
  • lateral sclerosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

PM1
In a hotspot region, there are 2 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 0 benign, 8 uncertain in NM_003119.4
PM5
Other missense variant is known to change same aminoacid residue: Variant chr16-89553919-C-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 1380458.We mark this variant Likely_pathogenic, oryginal submission is: [Conflicting_classifications_of_pathogenicity].
BP4
Computational evidence support a benign effect (MetaRNN=0.0019080639).
BP6
Variant 16-89553920-G-A is Benign according to our data. Variant chr16-89553920-G-A is described in ClinVar as [Benign]. Clinvar id is 130370.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.184 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SPG7NM_003119.4 linkc.2063G>A p.Arg688Gln missense_variant Exon 15 of 17 ENST00000645818.2 NP_003110.1 Q9UQ90-1
SPG7NM_001363850.1 linkc.2063G>A p.Arg688Gln missense_variant Exon 15 of 18 NP_001350779.1
SPG7XM_047434537.1 linkc.1190G>A p.Arg397Gln missense_variant Exon 10 of 13 XP_047290493.1
SPG7XM_047434540.1 linkc.749G>A p.Arg250Gln missense_variant Exon 7 of 9 XP_047290496.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SPG7ENST00000645818.2 linkc.2063G>A p.Arg688Gln missense_variant Exon 15 of 17 NM_003119.4 ENSP00000495795.2 Q9UQ90-1

Frequencies

GnomAD3 genomes
AF:
0.130
AC:
19841
AN:
152172
Hom.:
1646
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0355
Gnomad AMI
AF:
0.314
Gnomad AMR
AF:
0.120
Gnomad ASJ
AF:
0.236
Gnomad EAS
AF:
0.145
Gnomad SAS
AF:
0.146
Gnomad FIN
AF:
0.0852
Gnomad MID
AF:
0.165
Gnomad NFE
AF:
0.186
Gnomad OTH
AF:
0.163
GnomAD2 exomes
AF:
0.148
AC:
36840
AN:
249596
AF XY:
0.152
show subpopulations
Gnomad AFR exome
AF:
0.0316
Gnomad AMR exome
AF:
0.0887
Gnomad ASJ exome
AF:
0.218
Gnomad EAS exome
AF:
0.144
Gnomad FIN exome
AF:
0.0892
Gnomad NFE exome
AF:
0.189
Gnomad OTH exome
AF:
0.167
GnomAD4 exome
AF:
0.178
AC:
260547
AN:
1460152
Hom.:
24507
Cov.:
33
AF XY:
0.178
AC XY:
129313
AN XY:
726386
show subpopulations
African (AFR)
AF:
0.0284
AC:
949
AN:
33458
American (AMR)
AF:
0.0929
AC:
4153
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.219
AC:
5720
AN:
26128
East Asian (EAS)
AF:
0.127
AC:
5024
AN:
39698
South Asian (SAS)
AF:
0.143
AC:
12368
AN:
86230
European-Finnish (FIN)
AF:
0.0951
AC:
4977
AN:
52350
Middle Eastern (MID)
AF:
0.180
AC:
971
AN:
5394
European-Non Finnish (NFE)
AF:
0.194
AC:
215748
AN:
1111832
Other (OTH)
AF:
0.176
AC:
10637
AN:
60338
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.470
Heterozygous variant carriers
0
11798
23596
35393
47191
58989
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
7470
14940
22410
29880
37350
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.130
AC:
19833
AN:
152290
Hom.:
1644
Cov.:
33
AF XY:
0.126
AC XY:
9360
AN XY:
74464
show subpopulations
African (AFR)
AF:
0.0354
AC:
1473
AN:
41586
American (AMR)
AF:
0.120
AC:
1840
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.236
AC:
821
AN:
3472
East Asian (EAS)
AF:
0.145
AC:
748
AN:
5176
South Asian (SAS)
AF:
0.146
AC:
703
AN:
4828
European-Finnish (FIN)
AF:
0.0852
AC:
904
AN:
10616
Middle Eastern (MID)
AF:
0.170
AC:
50
AN:
294
European-Non Finnish (NFE)
AF:
0.186
AC:
12663
AN:
67990
Other (OTH)
AF:
0.163
AC:
345
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
870
1739
2609
3478
4348
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
230
460
690
920
1150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.174
Hom.:
4995
Bravo
AF:
0.128
TwinsUK
AF:
0.198
AC:
733
ALSPAC
AF:
0.203
AC:
784
ESP6500AA
AF:
0.0375
AC:
165
ESP6500EA
AF:
0.194
AC:
1667
ExAC
AF:
0.149
AC:
18099
Asia WGS
AF:
0.107
AC:
371
AN:
3478
EpiCase
AF:
0.196
EpiControl
AF:
0.198

ClinVar

Significance: Benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Hereditary spastic paraplegia 7 Benign:4
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Jul 15, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 14, 2017
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:2
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Hereditary spastic paraplegia Benign:1
Dec 12, 2016
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.10
BayesDel_addAF
Benign
-0.39
T
BayesDel_noAF
Benign
-0.19
CADD
Uncertain
23
DANN
Pathogenic
1.0
DEOGEN2
Benign
0.18
.;.;T;.;.;.;.;.;.
Eigen
Uncertain
0.25
Eigen_PC
Uncertain
0.36
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Benign
0.82
T;T;T;T;T;T;T;T;T
MetaRNN
Benign
0.0019
T;T;T;T;T;T;T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.69
.;.;N;.;.;.;.;.;.
PhyloP100
9.6
PrimateAI
Benign
0.47
T
REVEL
Uncertain
0.39
Polyphen
0.82
.;.;P;.;.;.;.;.;.
MPC
0.28
ClinPred
0.041
T
GERP RS
5.2
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.25
gMVP
0.68
Mutation Taster
=53/47
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs12960; hg19: chr16-89620328; COSMIC: COSV51951139; COSMIC: COSV51951139; API